Semax vs Selank – Research Peptide Comparison
Semax and Selank are synthetic peptides studied in laboratory environments for their interaction with neurochemical signalling pathways and central nervous system processes. Both compounds are widely referenced in neuroscience and biochemical research, particularly in studies involving neurotransmitter regulation and peptide signalling.
While they share similarities in origin and research application, Semax and Selank differ in their structural composition and areas of focus within laboratory models.
This guide compares Semax and Selank — two nootropic research peptides with distinct neurological mechanisms. Both Semax and Selank have been subjects of significant Russian academic research, with growing interest from the UK and international research community.
Overview of Each Peptide
Semax
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH), modified to enhance stability in laboratory environments.
It is commonly studied in:
- Neurotransmitter signalling pathways
- Brain-derived neurotrophic factor (BDNF) research
- Cognitive and neurobiology models
- Central nervous system signalling studies
Resources & Research Studies:
- Ashmarin et al. (1995) – Semax and ACTH-derived peptides in neurochemical research
- Volkova et al. (2000) – Semax and neurotrophic factor expression
- Dolotov et al. (2006) – Semax and central nervous system signalling pathways
Selank
Selank is a synthetic peptide derived from tuftsin, studied for its interaction with neurochemical signalling systems and peptide-mediated pathways.
It is commonly studied in:
- Neuropeptide signalling pathways
- Central nervous system research
- Neurotransmitter modulation studies
- Peptide signalling and regulatory models
Resources & Research Studies:
- Ashmarin et al. (1997) – Selank and neuropeptide signalling research
- Zozulya et al. (2008) – Selank and neurotransmitter interaction studies
- Volkova et al. (2010) – Selank and central nervous system pathways
Mechanism Comparison
| Feature | Semax | Selank |
|---|---|---|
| Origin | ACTH-derived peptide | Tuftsin-derived peptide |
| Primary Focus | Neurotrophic signalling | Neuropeptide signalling |
| Key Pathways | BDNF, neurotransmitters | Neurotransmitters, immune-related peptides |
| Research Type | Cognitive & CNS models | CNS & peptide signalling models |
Research Applications
Semax is commonly studied in: neurotransmitter signalling, neurotrophic factor expression (e.g. BDNF), cognitive and behavioural models, and central nervous system activity.
Selank is commonly studied in: neuropeptide signalling pathways, neurotransmitter modulation, central nervous system research, and peptide interaction studies.
Key Differences
- Semax is more associated with neurotrophic and signalling pathway research
- Selank is more focused on neuropeptide and regulatory signalling studies
- Semax is derived from ACTH fragments, while Selank is derived from tuftsin
- Both peptides interact with CNS pathways but through different mechanisms and research focuses
Important Notice: This content is provided for informational and research purposes only. All compounds mentioned are intended strictly for laboratory research use. They are not approved for human consumption.
Further Reading
- Peptide Library UK
- Complete Guide to Research Peptides UK
- Peptide Dosing Calculator
- Semax Research on PubMed
Frequently Asked Questions
What is the difference between Semax and Selank?
Both are synthetic peptides studied in laboratory environments for their interaction with neurochemical signalling pathways and central nervous system processes. While they share similarities in origin and research application, they differ in their structural composition and areas of focus within laboratory models.
What is Semax?
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH), modified to enhance stability in laboratory environments.
What is Semax studied for?
Semax is commonly studied in neurotransmitter signalling pathways, brain-derived neurotrophic factor (BDNF) research, cognitive and neurobiology models, and central nervous system signalling.
Are Semax and Selank approved medicines?
No. Both are referenced here for laboratory research purposes only and are not approved for human consumption or medical use.